Lv52
1600 积分 2024-04-25 加入
Diabetes in China: epidemiology, pathophysiology and multi-omics
8天前
已完结
Adherence to diabetes medication: a systematic review
8天前
已完结
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
1个月前
已完结
Obesity and Dyslipidemia: A Review of Current Evidence
1个月前
已完结
Novel Amylin Analogues Reduce Amyloid-β Cross-Seeding Aggregation and Neurotoxicity
1个月前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2个月前
已完结
Diabetes in China: epidemiology, pathophysiology and multi-omics
2个月前
已完结
Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China
2个月前
已完结
Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
2个月前
已完结
I018 TT-P34: a novel first-in-class peptide drug for treatment of Huntington’s Disease
3个月前
已完结
皖公网安备34019202002308
